Neogen director Capello receives 20,558 options

Both award types vest in equal annual installments on each of the first three anniversary dates of the grants.

Rhea-AI Filing Summary

NEOGEN CORP (NEOG) director Jeffrey D. Capello was granted 20,558 options to buy common stock and 9,804 restricted stock units on October 1, 2026. The options have an exercise price of $12.24 per share and expire October 1, 2036. The reported post-transaction position was 20,558 options and 42,306 shares, respectively. Both award types vest in equal annual installments on each of the first three anniversary dates of the grants.

Insider Trade Summary

Grant/Award: 30,362 shares

Grant/Award 2 txns

Insider CAPELLO JEFFREY D

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock (Right to Buy) F1	20,558	$0.00	$0.00
Grant/Award	Restricted Stock Units F1	9,804	$12.24	$120K

Holdings After Transaction: Common Stock (Right to Buy) — 20,558 contracts (Direct); Restricted Stock Units — 42,306 shares (Direct)

Footnotes (1)

1. F1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants

Key Figures

Options granted: 20,558 options Option exercise price: $12.24 per share Option expiration date: October 1, 2036 +3 more

6 metrics

Options granted 20,558 options Granted October 1, 2026

Option exercise price $12.24 per share Options to buy common stock

Option expiration date October 1, 2036 Granted October 1, 2026

Restricted stock units granted 9,804 units Granted October 1, 2026

Reported option position after grant 20,558 options Following the October 1, 2026 grant

Reported shares following RSU transaction 42,306 shares Following the October 1, 2026 award

Key Terms

Restricted Stock Units, exercise price, annual installments

3 terms

Restricted Stock Units financial

"Restricted Stock Units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

exercise price financial

"an exercise price of $12.24 per share"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

annual installments financial

"vest in equal annual installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did NEOG director Jeffrey D. Capello receive?

NEOGEN CORP director Jeffrey D. Capello received 20,558 options to buy common stock and 9,804 restricted stock units on October 1, 2026. The options have a $12.24-per-share exercise price and expire October 1, 2036. Both award types vest in equal annual installments on each of the first three grant anniversaries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/02/2026 - 10:58 AM Accepted by SEC EDGAR 10/02/2026 - 10:58 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

CAPELLO JEFFREY D

(Last) (First) (Middle)

C/O NEOGEN CORP.

620 LESHER PLACE

(Street)

LANSING MICHIGAN 48912

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Restricted Stock Units	10/01/2026		A		9,804(1)	A	$12.24	42,306	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock (Right to Buy)	$12.24	10/01/2026		A		20,558		(1)	10/01/2036	Common Stock	20,558	$0	20,558	D

Explanation of Responses:

1. Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants

	Christopher Sefcheck (attorney in fact)	10/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)